People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NanoPharmaceuticals LLC | — | Pharmaceuticals | Seed | $6.6M | $2.2M | 2025 |
Carl Walkey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Carl Walkey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Davis | 1 | 7 |
| Eliza A. Parker | 1 | 1 |
| Michael J. Rosenthal | 1 | 1 |
| Paul J. Davis | 1 | 1 |
| Shaker A. Mousa | 1 | 1 |
| James A. Gozzo | 1 | 1 |
| Eliza McKinney | 1 | 1 |
| Shaker Mousa | 1 | 1 |
| T. Gregory Dewey | 1 | 1 |
| Eliza J. Parker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.